Literature DB >> 31060435

Global brain volume reductions in a sub-chronic phencyclidine animal model for schizophrenia and their relationship to recognition memory.

Nazanin Doostdar1, Eugene Kim2, Ben Grayson1, Michael K Harte1, Joanna C Neill1, Anthony C Vernon3,4.   

Abstract

BACKGROUND: Cognitive deficits and structural brain changes co-occur in patients with schizophrenia. Improving our understanding of the relationship between these is important to develop improved therapeutic strategies. Back-translation of these findings into rodent models for schizophrenia offers a potential means to achieve this goal. AIMS: The purpose of this study was to determine the extent of structural brain changes and how these relate to cognitive behaviour in a sub-chronic phencyclidine rat model.
METHODS: Performance in the novel object recognition task was examined in female Lister Hooded rats at one and six weeks after sub-chronic phencyclidine (2 mg/kg intra-peritoneal, n=15) and saline controls (1 ml/kg intra-peritoneal, n=15). Locomotor activity following acute phencyclidine challenge was also measured. Brain volume changes were assessed in the same animals using ex vivo structural magnetic resonance imaging and computational neuroanatomical analysis at six weeks.
RESULTS: Female sub-chronic phencyclidine-treated Lister Hooded rats spent significantly less time exploring novel objects (p<0.05) at both time-points and had significantly greater locomotor activity response to an acute phencyclidine challenge (p<0.01) at 3-4 weeks of washout. At six weeks, sub-chronic phencyclidine-treated Lister Hooded rats displayed significant global brain volume reductions (p<0.05; q<0.05), without apparent regional specificity. Relative volumes of the perirhinal cortex however were positively correlated with novel object exploration time only in sub-chronic phencyclidine rats at this time-point.
CONCLUSION: A sustained sub-chronic phencyclidine-induced cognitive deficit in novel object recognition is accompanied by global brain volume reductions in female Lister Hooded rats. The relative volumes of the perirhinal cortex however are positively correlated with novel object exploration, indicating some functional relevance.

Entities:  

Keywords:  Cognitive dysfunction; atrophy; behaviour; magnetic resonance imaging; phencyclidine; rat; schizophrenia

Mesh:

Substances:

Year:  2019        PMID: 31060435     DOI: 10.1177/0269881119844196

Source DB:  PubMed          Journal:  J Psychopharmacol        ISSN: 0269-8811            Impact factor:   4.153


  5 in total

Review 1.  Neuroimaging Biomarkers in Schizophrenia.

Authors:  Nina V Kraguljac; William M McDonald; Alik S Widge; Carolyn I Rodriguez; Mauricio Tohen; Charles B Nemeroff
Journal:  Am J Psychiatry       Date:  2021-01-05       Impact factor: 19.242

2.  Mapping the impact of exposure to maternal immune activation on juvenile Wistar rat brain macro- and microstructure during early post-natal development.

Authors:  Tobias C Wood; Michelle E Edye; Michael K Harte; Joanna C Neill; Eric P Prinssen; Anthony C Vernon
Journal:  Brain Neurosci Adv       Date:  2019-11-04

3.  Dissociating the effects of distraction and proactive interference on object memory through tests of novelty preference.

Authors:  K Landreth; U Simanaviciute; J Fletcher; B Grayson; R A Grant; M H Harte; J Gigg
Journal:  Brain Neurosci Adv       Date:  2021-04-27

4.  A unique cerebellar pattern of microglia activation in a mouse model of encephalopathy of prematurity.

Authors:  Luisa Klein; Juliette Van Steenwinckel; Bobbi Fleiss; Till Scheuer; Christoph Bührer; Valerie Faivre; Sophie Lemoine; Corinne Blugeon; Leslie Schwendimann; Zsolt Csaba; Cindy Bokobza; Dulcie A Vousden; Jason P Lerch; Anthony C Vernon; Pierre Gressens; Thomas Schmitz
Journal:  Glia       Date:  2022-05-17       Impact factor: 8.073

5.  Brain volume in chronic ketamine users - relationship to sub-threshold psychotic symptoms and relevance to schizophrenia.

Authors:  Robert A Chesters; Fiona Pepper; Celia Morgan; Jonathan D Cooper; Oliver D Howes; Anthony C Vernon; James M Stone
Journal:  Psychopharmacology (Berl)       Date:  2021-07-06       Impact factor: 4.415

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.